Insulet Assumes Operations of Omnipod® Insulin System in Europe

Insulet Corporation has now assumed direct commercial operations in Europe to provide sales, distribution, customer support and product services for its Omnipod System. They have established a dedicated Customer Care team, to support its European customer base.

Since July 2017, when Insulet announced its intention to assume the distribution, sales, marketing, training and support activities for the Omnipod System across Europe, the company has established a European team of over 100 employees with extensive diabetes knowledge and expertise within the European markets. In addition,  the company now has 24/7 customer care and product support for over 140,000 Podders™ worldwide.

Patrick Sullivan, Chairman and Chief Executive Officer, said: “We are thrilled to directly support the diabetes community across Europe now and into the future.”

Professor Eric Renard, Professor of Endocrinology, Lapeyronie University Hospital, Montpellier, France said: “Insulet is making a significant, long-term commitment to the diabetes community in Europe.”